The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

By 2012, saddled with billions in debt, Kodak filed for Chapter 11 bankruptcy. However, Zhang traced the decay back even ...

The Zacks Electronics – Testing Equipment industry has been suffering from a challenging global macroeconomic environment, ...

The National Institute for Pharmaceutical Research and Development (NIPRD) has called for stronger coordination, longer policy timelines, and improved industry awareness to accelerate local medicine ...

The new North Chicago facility, slated to open in 2027, will boost domestic production of key drug ingredients for immunology ...

What Happened: MD's decision to sell 11,659 shares of Collegium Pharmaceutical was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value of the sale ...

Texas AG Ken Paxton sues Eli Lilly for alleged bribery to promote diabetes drugs, claiming violation of state fraud laws and ...

A new FDA program will use a two-phase approach to help boost domestic drug manufacturing, while OpenAI is leaning into health care with the launch of GPT-5.

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...